Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02160002
Other study ID # NICHD-NRN-0054
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2015
Est. completion date June 2017

Study information

Verified date March 2019
Source NICHD Neonatal Research Network
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this proposal is to evaluate whether weaning from an incubator to a crib at lower versus higher weight, 1600g or 1800g will result in shorter length of hospital stay among moderately preterm infants.

The hypothesis of this study is that length of hospital stay (from birth to discharge) will be decreased among moderate preterm infants weaned from an incubator to an open crib at a lower versus higher weight, 1600g vs. 1800g.


Recruitment information / eligibility

Status Completed
Enrollment 366
Est. completion date June 2017
Est. primary completion date July 2016
Accepts healthy volunteers No
Gender All
Age group 29 Weeks to 34 Weeks
Eligibility Inclusion Criteria:

- Gestational age 29 0/7 to 33 6/7 weeks at birth

- Birth weight less than 1600 grams

- Greater than 48 hours of age

- Current weight less than 1540 grams

- In an incubator

Exclusion Criteria:

- Receiving phototherapy

- Receiving respiratory support (including CPAP, ventilation, HFNC > 2 LPM)

- Receiving blood pressure support

- Designated for transfer to referral hospital while in incubator

- Known major congenital or chromosomal anomaly

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Weaning from an incubator at a lower weight (1600 grams)
Infants will be weaned from an incubator at a lower weight (1600 grams)
Weaning from an incubator at a higher weight (1800 grams)
Infants will be weaned from an incubator at a higher weight (1800 grams)

Locations

Country Name City State
United States University of New Mexico Albuquerque New Mexico
United States Emory University Atlanta Georgia
United States University of Alabama at Birmingham Birmingham Alabama
United States Cincinnati Children's Medical Center Cincinnati Ohio
United States Case Western Reserve University Cleveland Ohio
United States Research Institute at Nationwide Children's Hospital Columbus Ohio
United States University of Texas Southwestern Medical Center at Dallas Dallas Texas
United States Wayne State University Detroit Michigan
United States Duke University Durham North Carolina
United States RTI International Durham North Carolina
United States Indiana University Indianapolis Indiana
United States University of Iowa Iowa City Iowa
United States Children's Mercy Hospital Kansas City Missouri
United States University of California - Los Angeles Los Angeles California
United States Stanford University Palo Alto California
United States Univeristy of Pennsylvania Philadelphia Pennsylvania
United States Brown University, Women & Infants Hospital of Rhode Island Providence Rhode Island
United States University of Rochester Rochester New York

Sponsors (2)

Lead Sponsor Collaborator
NICHD Neonatal Research Network Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Length of Hospital Stay (LOS) From Birth to Discharge (up to 120 Days) Number of days the infant stays in hospital after birth until discharge home (up to 120 days). From birth through discharge
Secondary Length of Stay (LOS) Following Weaning From Incubator to Crib to Hospital Discharge (up to 120 Days) Among infants who were successfully weaned, the number of days in the hospital counting from the start of weaning from the incubator to the crib through discharge from the hospital (up to 120 days). From start of weaning from the incubator to crib through discharge (up to 120 days)
Secondary Failure Rate of Weaning to Crib (Number of Infants With Axillary Temperature < 36.3°C After 2 Weaning Attempts) Failure of wean is defined as axillary temperature less than 36.3°C after one hour in the crib on 2 successive readings, 3 to 4 hours apart, within 24 hours of weaning to the crib in spite of additional clothes/coverings. Through completion of 2 weaning attempts
Secondary Growth Velocity (Weight in Grams/kg/Day) From Start of Weaning From Incubator (Following Random Assignment) to 36 Weeks Postmenstrual Age (PMA) Growth velocity in terms of weight (g/kg/day), considering infant weight at start of weaning from incubator to crib (following random assignment) and weight at 36 weeks postmenstrual age (PMA). Start of weaning from incubator through 36 weeks postmenstrual age (PMA)
Secondary Growth Parameters: Weight at Status Infant weight at status is measured at the time of discharge, death, transfer to another facility, or 120 days. Status (discharge, death, transfer to another facility, or 120 days)
Secondary Growth Parameters: Length at Status Infant length at status is measured at the time of discharge, death, transfer to another facility, or 120 days. Status (discharge, death, transfer to another facility, or 120 days)
Secondary Growth Parameters: Head Circumference at Status Infant head circumference at status is measured at the time of discharge, death, transfer to another facility, or 120 days. Status (discharge, death, transfer to another facility, or 120 days)
Secondary Postmenstrual Age (PMA) at Discharge Postmenstrual age (PMA) at discharge is the sum of the gestational age of the infant and its length of stay in hospital from birth to discharge. Discharge
Secondary Readmission to the Hospital Within 1 Week of Discharge Number of infants re-hospitalized within 1 week (7 days) of discharge. Discharge through 1 week after discharge.
Secondary Death Among Enrolled Infants Status (discharge, death, transfer to another facility, or 120 days)
Secondary Transferred to a Non-Network Hospital Number of infants transferred to another non-Network hospital. Status (discharge, death, transfer to another facility, or 120 days)
Secondary Length of Stay (LOS) Following Randomization to Hospital Discharge The number of days the infant stayed in hospital after randomization to the study until discharge. From randomization through discharge.
See also
  Status Clinical Trial Phase
Completed NCT04994652 - Video- Or Direct Laryngoscopy for Endotracheal Intubation in Newborns N/A
Completed NCT02064712 - Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates N/A
Withdrawn NCT01335919 - Neonatal Non-Invasive Hemoglobin Determination N/A
Terminated NCT01192776 - Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE) N/A
Completed NCT00114543 - Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight Phase 3
Completed NCT00011362 - Dexamethasone Therapy in VLBW Infants at Risk of CLD Phase 3
Recruiting NCT05001334 - Effect of Kangaroo Care on Phyiological Weight Loss in Term Newborns N/A
Completed NCT01193270 - Vitamin E for Extremely Preterm Infants Phase 1
Completed NCT00005772 - Whole-Body Cooling for Birth Asphyxia in Term Infants Phase 3
Terminated NCT00005776 - Inhaled Nitric Oxide Study for Respiratory Failure in Newborns Phase 3
Completed NCT01203423 - Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study
Completed NCT06120062 - Effect of Swaddling and Inhaling Breast Milk Odour on the Pain and Comfort
Completed NCT00820677 - Newborn Health Information Study N/A
Active, not recruiting NCT00189384 - Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants Phase 3
Completed NCT01203410 - Prediction of Jaundice in Term Infants
Recruiting NCT03745963 - The Influence of Skin-to-skin Contact on Cortical Activity During Painful Procedures on Preterm Infants in the NICU Phase 3
Completed NCT04050384 - Effect of a Vibratory Stimulus on Mitigating Nociception-specific Responses to Skin Puncture in Neonates N/A
Completed NCT01793129 - Preemie Hypothermia for Neonatal Encephalopathy N/A
Withdrawn NCT00598429 - Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure Phase 2
Completed NCT01223287 - Physiologic Definition of Bronchopulmonary Dysplasia N/A